HEADER TRANSFERASE 29-JUL-16 5LMA TITLE HUMAN SPLEEN TYROSINE KINASE KINASE DOMAIN IN COMPLEX WITH TITLE 2 AZANAPHTHYRIDINE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE SYK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 360-635; COMPND 5 SYNONYM: SPLEEN TYROSINE KINASE,P72-SYK; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SYK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1-HM KEYWDS INHIBITOR, COMPLEX, KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR D.O.SOMERS,M.NEU REVDAT 4 06-NOV-24 5LMA 1 REMARK REVDAT 3 01-MAY-24 5LMA 1 REMARK REVDAT 2 21-SEP-16 5LMA 1 JRNL REVDAT 1 14-SEP-16 5LMA 0 JRNL AUTH N.S.GARTON,M.D.BARKER,R.P.DAVIS,C.DOUAULT, JRNL AUTH 2 E.HOOPER-GREENHILL,E.JONES,H.D.LEWIS,J.LIDDLE,D.LUGO, JRNL AUTH 3 S.MCCLEARY,A.G.PRESTON,C.RAMIREZ-MOLINA,M.NEU,T.J.SHIPLEY, JRNL AUTH 4 D.O.SOMERS,R.J.WATSON,D.M.WILSON JRNL TITL OPTIMISATION OF A NOVEL SERIES OF POTENT AND ORALLY JRNL TITL 2 BIOAVAILABLE AZANAPHTHYRIDINE SYK INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 26 4606 2016 JRNL REFN ESSN 1464-3405 JRNL PMID 27578246 JRNL DOI 10.1016/J.BMCL.2016.08.070 REMARK 2 REMARK 2 RESOLUTION. 1.43 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0073 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.43 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 3 NUMBER OF REFLECTIONS : 44455 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.157 REMARK 3 R VALUE (WORKING SET) : 0.156 REMARK 3 FREE R VALUE : 0.183 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2306 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.43 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.47 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2742 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 80.65 REMARK 3 BIN R VALUE (WORKING SET) : 0.1880 REMARK 3 BIN FREE R VALUE SET COUNT : 146 REMARK 3 BIN FREE R VALUE : 0.1870 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2184 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 39 REMARK 3 SOLVENT ATOMS : 453 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.52 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.82 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.52000 REMARK 3 B22 (A**2) : -0.43000 REMARK 3 B33 (A**2) : -0.17000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.29000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.067 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.068 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.039 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 0.973 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.973 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.958 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2393 ; 0.006 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2271 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3237 ; 1.188 ; 1.964 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5243 ; 0.736 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 292 ; 4.283 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 111 ;35.258 ;24.685 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 438 ;10.428 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;16.493 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 331 ; 0.081 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2731 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 556 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1138 ; 1.320 ; 3.022 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1137 ; 1.318 ; 3.019 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1440 ; 2.037 ; 5.079 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 5LMA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-JUL-16. REMARK 100 THE DEPOSITION ID IS D_1200000938. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-FEB-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97950 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.12 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46803 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.430 REMARK 200 RESOLUTION RANGE LOW (A) : 43.730 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : 0.03200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.43 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.51 REMARK 200 COMPLETENESS FOR SHELL (%) : 85.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : 0.10700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: IN-HOUSE COORDINATES REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG3350, SODIUM FORMATE., VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 43.72700 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 640 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13290 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 359 REMARK 465 PRO A 360 REMARK 465 LYS A 361 REMARK 465 GLU A 362 REMARK 465 THR A 530 REMARK 465 HIS A 531 REMARK 465 VAL A 633 REMARK 465 VAL A 634 REMARK 465 ASN A 635 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 841 O HOH A 1030 1.86 REMARK 500 OH TYR A 526 O HOH A 801 2.12 REMARK 500 OG SER A 553 O HOH A 802 2.18 REMARK 500 O HOH A 872 O HOH A 910 2.19 REMARK 500 NZ LYS A 386 O HOH A 803 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 375 111.60 -160.26 REMARK 500 LYS A 394 -55.04 -144.48 REMARK 500 ALA A 441 -126.94 -140.43 REMARK 500 ASP A 494 39.29 -150.09 REMARK 500 ASP A 512 65.54 63.43 REMARK 500 TRP A 609 32.83 -93.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6ZG A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 703 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 704 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5LMB RELATED DB: PDB DBREF 5LMA A 360 635 UNP P43405 KSYK_HUMAN 360 635 SEQADV 5LMA GLY A 359 UNP P43405 EXPRESSION TAG SEQRES 1 A 277 GLY PRO LYS GLU VAL TYR LEU ASP ARG LYS LEU LEU THR SEQRES 2 A 277 LEU GLU ASP LYS GLU LEU GLY SER GLY ASN PHE GLY THR SEQRES 3 A 277 VAL LYS LYS GLY TYR TYR GLN MET LYS LYS VAL VAL LYS SEQRES 4 A 277 THR VAL ALA VAL LYS ILE LEU LYS ASN GLU ALA ASN ASP SEQRES 5 A 277 PRO ALA LEU LYS ASP GLU LEU LEU ALA GLU ALA ASN VAL SEQRES 6 A 277 MET GLN GLN LEU ASP ASN PRO TYR ILE VAL ARG MET ILE SEQRES 7 A 277 GLY ILE CYS GLU ALA GLU SER TRP MET LEU VAL MET GLU SEQRES 8 A 277 MET ALA GLU LEU GLY PRO LEU ASN LYS TYR LEU GLN GLN SEQRES 9 A 277 ASN ARG HIS VAL LYS ASP LYS ASN ILE ILE GLU LEU VAL SEQRES 10 A 277 HIS GLN VAL SER MET GLY MET LYS TYR LEU GLU GLU SER SEQRES 11 A 277 ASN PHE VAL HIS ARG ASP LEU ALA ALA ARG ASN VAL LEU SEQRES 12 A 277 LEU VAL THR GLN HIS TYR ALA LYS ILE SER ASP PHE GLY SEQRES 13 A 277 LEU SER LYS ALA LEU ARG ALA ASP GLU ASN PTR TYR LYS SEQRES 14 A 277 ALA GLN THR HIS GLY LYS TRP PRO VAL LYS TRP TYR ALA SEQRES 15 A 277 PRO GLU CYS ILE ASN TYR TYR LYS PHE SER SER LYS SER SEQRES 16 A 277 ASP VAL TRP SER PHE GLY VAL LEU MET TRP GLU ALA PHE SEQRES 17 A 277 SER TYR GLY GLN LYS PRO TYR ARG GLY MET LYS GLY SER SEQRES 18 A 277 GLU VAL THR ALA MET LEU GLU LYS GLY GLU ARG MET GLY SEQRES 19 A 277 CYS PRO ALA GLY CYS PRO ARG GLU MET TYR ASP LEU MET SEQRES 20 A 277 ASN LEU CYS TRP THR TYR ASP VAL GLU ASN ARG PRO GLY SEQRES 21 A 277 PHE ALA ALA VAL GLU LEU ARG LEU ARG ASN TYR TYR TYR SEQRES 22 A 277 ASP VAL VAL ASN MODRES 5LMA PTR A 525 TYR MODIFIED RESIDUE HET PTR A 525 16 HET 6ZG A 701 23 HET GOL A 702 6 HET GOL A 703 6 HET DMS A 704 4 HETNAM PTR O-PHOSPHOTYROSINE HETNAM 6ZG ~{N}'-[7-(4-METHYLPHENYL)PYRIDO[3,4-B]PYRAZIN-5- HETNAM 2 6ZG YL]BUTANE-1,4-DIAMINE HETNAM GOL GLYCEROL HETNAM DMS DIMETHYL SULFOXIDE HETSYN PTR PHOSPHONOTYROSINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 PTR C9 H12 N O6 P FORMUL 2 6ZG C18 H21 N5 FORMUL 3 GOL 2(C3 H8 O3) FORMUL 5 DMS C2 H6 O S FORMUL 6 HOH *453(H2 O) HELIX 1 AA1 ASP A 366 LYS A 368 5 3 HELIX 2 AA2 ASN A 406 ASN A 409 5 4 HELIX 3 AA3 ASP A 410 GLN A 426 1 17 HELIX 4 AA4 LEU A 456 ASN A 463 1 8 HELIX 5 AA5 LYS A 467 SER A 488 1 22 HELIX 6 AA6 ALA A 496 ARG A 498 5 3 HELIX 7 AA7 PRO A 535 TYR A 539 5 5 HELIX 8 AA8 ALA A 540 TYR A 547 1 8 HELIX 9 AA9 SER A 551 SER A 567 1 17 HELIX 10 AB1 LYS A 577 LYS A 587 1 11 HELIX 11 AB2 PRO A 598 TRP A 609 1 12 HELIX 12 AB3 GLY A 618 TYR A 631 1 14 SHEET 1 AA1 5 LEU A 370 GLY A 380 0 SHEET 2 AA1 5 GLY A 383 GLN A 391 -1 O TYR A 389 N THR A 371 SHEET 3 AA1 5 VAL A 396 LEU A 404 -1 O ILE A 403 N THR A 384 SHEET 4 AA1 5 TRP A 444 GLU A 449 -1 O MET A 448 N ALA A 400 SHEET 5 AA1 5 MET A 435 GLU A 440 -1 N GLY A 437 O VAL A 447 SHEET 1 AA2 3 GLY A 454 PRO A 455 0 SHEET 2 AA2 3 VAL A 500 THR A 504 -1 O LEU A 502 N GLY A 454 SHEET 3 AA2 3 TYR A 507 ILE A 510 -1 O LYS A 509 N LEU A 501 SHEET 1 AA3 2 PHE A 490 VAL A 491 0 SHEET 2 AA3 2 LYS A 517 ALA A 518 -1 O LYS A 517 N VAL A 491 SHEET 1 AA4 2 PTR A 525 LYS A 527 0 SHEET 2 AA4 2 LYS A 548 SER A 550 -1 O PHE A 549 N TYR A 526 LINK C AASN A 524 N PTR A 525 1555 1555 1.33 LINK C BASN A 524 N PTR A 525 1555 1555 1.33 LINK C PTR A 525 N TYR A 526 1555 1555 1.33 SITE 1 AC1 14 LEU A 377 VAL A 385 ALA A 400 GLU A 449 SITE 2 AC1 14 MET A 450 ALA A 451 GLU A 452 GLY A 454 SITE 3 AC1 14 ARG A 498 ASN A 499 LEU A 501 ASP A 512 SITE 4 AC1 14 GOL A 702 HOH A1004 SITE 1 AC2 9 VAL A 385 LYS A 402 GLU A 420 MET A 448 SITE 2 AC2 9 SER A 511 ASP A 512 6ZG A 701 HOH A 829 SITE 3 AC2 9 HOH A 835 SITE 1 AC3 7 VAL A 363 ALA A 421 ASN A 422 GLN A 425 SITE 2 AC3 7 HOH A 862 HOH A 888 HOH A 958 SITE 1 AC4 4 ASN A 406 GLN A 477 TYR A 507 HOH A1057 CRYST1 39.175 87.454 39.851 90.00 99.64 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025526 0.000000 0.004335 0.00000 SCALE2 0.000000 0.011435 0.000000 0.00000 SCALE3 0.000000 0.000000 0.025453 0.00000